Skip to main content
Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc. — Investor Relations & Filings

Ticker · GLUE ISIN · US61225M1027 US Manufacturing
Filings indexed 324 across all filing types
Latest filing 2024-06-13 Director's Dealing
Country US United States of America
Listing US GLUE

About Monte Rosa Therapeutics, Inc.

https://www.monterosatx.com/

Monte Rosa Therapeutics is a clinical-stage biotechnology company that develops small molecule precision medicines known as molecular glue degraders (MGDs). The company's proprietary drug discovery platform is engineered to rationally design MGDs that leverage the body's natural protein disposal system to selectively eliminate disease-causing proteins. This approach targets proteins that have been historically considered "undruggable" or are inadequately addressed by existing therapies. By integrating expertise in chemistry, artificial intelligence, structural biology, and proteomics, Monte Rosa is advancing a pipeline of therapeutic candidates primarily for cancer and other serious diseases.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2024-06-13 English
4
Director's Dealing
2024-06-13 English
4
Director's Dealing
2024-06-13 English
4
Director's Dealing
2024-06-13 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated June 12, 2024, reporting the results of the 2024 Annual Meeting of Stockholders of Monte Rosa Therapeutics, Inc. It details the voting results on director elections and ratification of the independent auditor. The content focuses on the submission of matters to vote of security holders and the official voting outcomes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not a full annual report, audit report, or proxy statement, but specifically the official voting results from the annual meeting. The length and detail confirm it is not a brief announcement but a full voting results report.
2024-06-12 English
4
Director's Dealing
2024-06-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.